| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/1533317515628053 |
| P698 | PubMed publication ID | 26888864 |
| P50 | author | Hubert H Fernandez | Q67167621 |
| S E Jones | Q87718806 | ||
| James B Leverenz | Q46249399 | ||
| P2093 | author name string | Justis P Ehlers | |
| Jagan A Pillai | |||
| Alexander Rae-Grant | |||
| Aaron Bonner-Jackson | |||
| James Bena | |||
| Robert Bermel | |||
| P2860 | cites work | Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration? | Q46418403 |
| Analysis of normal retinal nerve fiber layer thickness by age, sex, and race using spectral domain optical coherence tomography | Q46420070 | ||
| Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease | Q48148917 | ||
| Retinal alterations in mild cognitive impairment and Alzheimer's disease: an optical coherence tomography study. | Q50642694 | ||
| Microvascular network alterations in the retina of patients with Alzheimer's disease. | Q50864313 | ||
| Retinal ganglion cells in Alzheimer's disease and aging. | Q51053350 | ||
| Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. | Q51920606 | ||
| Retinal nerve fiber layer abnormalities in Alzheimer's disease. | Q52889545 | ||
| Optic-nerve degeneration in Alzheimer's disease. | Q53194632 | ||
| Abnormal pattern electroretinograms in patients with senile dementia of the Alzheimer type. | Q53301889 | ||
| The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29547554 | ||
| The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29614406 | ||
| The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment | Q29615678 | ||
| Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration | Q30499517 | ||
| An evaluation of the retinal nerve fiber layer thickness by scanning laser polarimetry in individuals with dementia of the Alzheimer type | Q31890756 | ||
| Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging | Q33264775 | ||
| Retinal abnormalities in early Alzheimer's disease | Q33282836 | ||
| The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease | Q33631292 | ||
| Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer's disease | Q34135059 | ||
| Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model | Q34349078 | ||
| Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q34988061 | ||
| Myelinated axon number in the optic nerve is unaffected by Alzheimer's disease | Q37313281 | ||
| Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis | Q37499629 | ||
| Retinopathy in Parkinson Disease | Q37591956 | ||
| Retinal pathology as biomarker for cognitive impairment and Alzheimer's disease | Q38021660 | ||
| Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: evidence in optical coherence tomography | Q42977904 | ||
| Neuroretinal function is normal in early dementia of the Alzheimer type | Q43668248 | ||
| Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina | Q44607138 | ||
| Retinal nerve fiber layer thinning in Parkinson disease | Q45040652 | ||
| Optic nerve head and nerve fiber layer in Alzheimer's disease | Q45282825 | ||
| Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL. | Q46006000 | ||
| Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease | Q46066176 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| dementia | Q83030 | ||
| Alzheimer's disease | Q11081 | ||
| P304 | page(s) | 430-436 | |
| P577 | publication date | 2016-02-16 | |
| P1433 | published in | American Journal of Alzheimer's Disease & Other Dementias | Q4744232 |
| P1476 | title | Retinal Nerve Fiber Layer Thinning in Alzheimer's Disease: A Case-Control Study in Comparison to Normal Aging, Parkinson's Disease, and Non-Alzheimer's Dementia | |
| P478 | volume | 31 |
| Q48229261 | Absence of Alzheimer Disease Neuropathologic Changes in Eyes of Subjects With Alzheimer Disease |
| Q92267906 | Association of Cognitive Function with Amyloid-β and Tau Proteins in the Vitreous Humor |
| Q55026294 | Change in retinal structural anatomy during the preclinical stage of Alzheimer's disease. |
| Q41738955 | Collaborative SDOCT Segmentation and Analysis Software |
| Q90932818 | Ganglion cell layer thinning in prodromal Alzheimer's disease defined by amyloid PET |
| Q92027877 | Identification of Retinal Biomarkers in Alzheimer's Disease Using Optical Coherence Tomography: Recent Insights, Challenges, and Opportunities |
| Q40148621 | OCT in Alzheimer's disease: thinning of the RNFL and superior hemiretina |
| Q90372683 | Olfactory and other sensory impairments in Alzheimer disease |
| Q47221811 | Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases. |
| Q92370659 | Optical coherence tomography findings in chronic progressive external ophthalmoplegia |
| Q55262235 | Outer Retinal Assessment Using Spectral-Domain Optical Coherence Tomography in Patients With Alzheimer's and Parkinson's Disease. |
| Q64764728 | Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases |
| Q49761625 | Patterns of Retinal Ganglion Cell Damage in Neurodegenerative Disorders: Parvocellular vs Magnocellular Degeneration in Optical Coherence Tomography Studies |
| Q92799333 | Perifovea retinal thickness as an ophthalmic biomarker for mild cognitive impairment and early Alzheimer's disease |
| Q92708941 | Peripapillary retinal nerve fiber layer and ganglion cell complex degeneration in Egyptian patients with bipolar disorder |
| Q91944498 | Reflections on the Utility of the Retina as a Biomarker for Alzheimer's Disease: A Literature Review |
| Q91936690 | Retinal correlates of neurological disorders |
| Q91781268 | Retinal layer thickness in preclinical Alzheimer's disease |
| Q36214568 | Retinal microvascular network alterations: potential biomarkers of cerebrovascular and neural diseases |
| Q64921741 | Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease. |
| Q91997246 | Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer's disease |
| Q46060177 | Retinal thickness correlates with parietal cortical atrophy in early-onset Alzheimer's disease and controls |
| Q37670223 | Retinal thickness in Alzheimer's disease: A systematic review and meta-analysis. |
| Q37679166 | Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer's disease. |
| Q47095979 | The c-jun N-terminal kinase plays a key role in ocular degenerative changes in a mouse model of Alzheimer disease suggesting a correlation between ocular and brain pathologies. |
| Q90537022 | Validation of Optical Coherence Tomography Retinal Segmentation in Neurodegenerative Disease |
Search more.